09/28/2022
RICHLAND, WASHINGTON – September 28, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
09/21/2022
Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September 21, 2022 ...
06/21/2022
RICHLAND, WASHINGTON – June 21, 2022 – The growing body of information regarding Isoray, Inc.’s (NYSE American: ...
06/15/2022
RICHLAND, WASHINGTON – June 15, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
05/10/2022
Revenue Increased 12% Year-Over-Year
Record Non-Prostate Brachytherapy Revenue Increased 28% ...
04/29/2022
Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – April 29, 2022 – ...
03/10/2022
Isoray to Participate in the Oppenheimer
32nd Annual Healthcare Conference RICHLAND, WASHINGTON – March 10, ...
03/02/2022
Study Finds Excellent Outcomes for Intermediate Risk
Prostate Cancer Patients Treated with Isoray’s ...
02/08/2022
Revenue Increased 19% Year-Over-Year
Prostate Brachytherapy Revenue Increased 13% Year-Over-Year RICHLAND, ...
01/26/2022
Conference Call is Tuesday, February 8, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – January 26, 2022
11/10/2021
Prostate Revenue Increased Year-Over-Year for Second Consecutive Quarter Non-Prostate Brachytherapy Revenue ...
10/29/2021
Conference Call is Wednesday, November 10, 2021 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON –October 29, ...
